StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > SZLS will soon add Glioblastoma and Pancreatic cancer to...

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Nov 28, 2022 1:06pm

77 Views

Post# 35134207

RE:RE:RE:SZLS will soon add Glioblastoma and Pancreatic cancer to...

Your post made me buy another share. Now I have 2.

12:40:53	M	0.07		1	80 National Bank	80 National Bank
11:37:00	H	0.07		1,000	124 Questrade	80 National Bank	K
11:37:00	T	0.07		3,000	124 Questrade	5 Citadel	K
11:37:00	T	0.07		6,000	124 Questrade	1 Anonymous	K
10:18:19	D	0.07		43	80 National Bank	79 CIBC	E
10:18:19	T	0.07		1,000	2 RBC	1 Anonymous	K
09:54:13	T	0.07		19,000	2 RBC	124 Questrade	K
09:52:36	T	0.075	0.005	1,000	53 Morgan Stanley	1 Anonymous	KL
09:30:00	D	0.075	0.005	1	80 National Bank	80 National Bank	E
09:30:00	T	0.07		4	5 Citadel	14 Virtu ITG

Liked2Think wrote:

IainCaimbeul wrote: Another one of gojotv's fairy tales. Going forward Aristotle may well add other diseases to the platform; tieingTripp and Idle together is pure speculation.

gojotv! wrote: It's Aristotle diagnostic blood test.
Both those cancers are difficult to diagnose in the early stages, and will elicit real interest in Aristotle.
I wonder if Eric Idle's pancreatic cancer was found by Aristotle-involved researchers...? I mean, he said his cancer was found by a friend at Cambridge working on a new test... and Tripp is a Cambridge alum who's about in Eric Idle's age group...
This is getting very interesting...
GLTA investors!

so the plan with a product that no one buys is to make a better version of it?

I thought Aristotle was a better colonsentry?

nothing has sold